When stocks are attractive, you buy them. Sure, they can go lower. I’ve bought stocks at $12 that went to $2, but then they later went to $30.
I'm a person who likes to be different.
The ethical debate around CRISPR is as important as the science itself.
Rosneft’s strategy is built on long-term value creation, not short-term gains.